Cargando…
Creation of GMP-Compliant iPSCs From Banked Umbilical Cord Blood
Many clinical trials are in progress using cells derived from induced pluripotent stem cells (iPSC) for immunotherapies and regenerative medicine. The success of these new therapies is underpinned by the quality of the cell population used to create the iPSC lines, along with the creation of iPSCs i...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967326/ https://www.ncbi.nlm.nih.gov/pubmed/35372371 http://dx.doi.org/10.3389/fcell.2022.835321 |